Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

That matters because every pound that stays in the pot has a better chance to compound. But how does a modest daily habit turn into a five-year head start on retirement?

Crunching the numbers

A tenner a day is £3,650 a year, or about £304 a month. If that money compounds at 9.5% a year for 30 years, the pot could grow to about £546,359. 

Using that rough estimate, you could calculate potential income. At the recommended 4% retirement withdrawal rate, it would provide £21,854 a year of income. An investor that requires more (or less) can adjust that rate.

Here’s a few examples:

So as you can see, a 30-year-old investing just a small amount each day could build a large enough pot to retire several years earlier than anticipated.

The catch is obvious: the 9.5% return isn’t guaranteed, so the portfolio has to be built with care. A badly-planned portfolio would deliver far less, meaning you wouldn’t be able to retire nearly as soon.

A portfolio snapshot

For a novice investor, I would keep the structure simple:

Now, these aren’t just random picks. Let me use Experian as an example of what to consider in retirement stocks.

Why Experian works

Experian suits a 30-year retirement plan because it earns repeat business from credit data, fraud checks and identity services. That gives it recurring revenue and high barriers to entry. It also has a long runway for growth as more of life moves online and more lenders rely on data.

FY26 results were strong. Revenue reached $8.45bn, up 12%, organic growth was 8%, and earnings per share (EPS) rose 15% to 179.8c. It also announced a 69.25c full-year dividend and a new $1bn share buyback, while guiding for another year of double-digit EPS growth in FY2027.

It helps diversify a portfolio too, since it’s very different from an oil major or utility. The main risk is valuation: if growth disappoints, the share price can fall sharply. So on the right entry price, it can be a steady, long-term compounder — but not a flashy trade.

Final thoughts

The big lesson is simple. Start early, keep contributing, and build a portfolio you can stick with. I’d rather own a sensible mix of strong businesses for 30 years than chase hype stocks for a quick win. 

Regular investing, not lucky timing, is what gives £10 a day the chance to change retirement age. That’s the real edge for an ordinary saver — and there’s many more stocks than these to choose from.

Should you invest £5,000 in Experian Plc right now?

When investing expert Mark Rogers and his team have a stock tip, it can pay to listen. After all, the flagship Twelfth Magpie Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Experian Plc made the list?

Mark Hartley owns shares in National Grid, Unilever, Diageo and Experian.

The post Here’s how £10 a day invested in the stock market can cut down retirement age by 5 years appeared first on The Twelfth Magpie.

Yet, none of those explanations obviously fits Experian (LSE: EXPN). The business continues to deliver solid growth and management remains confident about the future.

So, why have the shares fallen so heavily over the past year?

Changing sentiment

Much of the recent weakness appears to stem from changing investor expectations rather than deteriorating business performance.

During the post-pandemic boom, investors were willing to pay a premium for high-quality companies capable of delivering consistent growth. However, higher interest rates and a more uncertain economic outlook have made the market less willing to pay elevated valuations.

At the same time, the rapid rise of artificial intelligence has prompted questions about whether traditional information and data businesses could face new competitive threats.

Companies such as Experian and RELX derive much of their value from proprietary datasets and analytics, but some investors worry that new AI-driven business models could alter the competitive landscape.

As a result, sentiment towards the shares has weakened, even though the underlying business has continued to grow.

Has the market got this all wrong?

At the heart of the investment debate is a simple question: what happens if credit growth slows?

With household debt levels elevated in many markets, banks could become more selective about lending and consumers may borrow less. On the surface, that sounds like bad news for a company whose roots lie in credit reporting.

However, I think there is another side to the story. Despite often being viewed as a credit bureau, Experian has evolved into a far more diversified business. Today, it generates revenue from healthcare, automotive, fraud prevention, analytics, and software solutions, helping it deliver growth through a wide range of economic environments.

That resilience is important because much of the company’s growth now comes from developing new products and extracting greater value from its data assets rather than simply benefiting from higher lending volumes.

I’m also not convinced AI is necessarily the threat some investors fear. While new models may change how information is accessed, they still require high-quality data to produce useful outcomes. The company’s competitive advantage lies in the vast proprietary datasets it has built over decades, which are difficult for rivals to replicate.

If anything, greater use of AI could increase demand for trusted data and analytics rather than reduce it.

What’s the verdict?

Ultimately, I think the debate comes down to expectations. Experian is unlikely to deliver explosive growth, and the days when investors were willing to pay almost any price for high-quality data businesses may be over.

However, the company continues to grow organically, generate strong cash flows, and invest in new opportunities across analytics and fraud prevention. While some investors appear concerned that AI could undermine its competitive position, I see a reasonable case that trusted proprietary data becomes even more valuable as AI adoption increases.

That doesn’t mean the shares will immediately return to their previous highs. Investor sentiment can remain weak for extended periods, particularly when growth expectations are being reset across the market.

Nevertheless, for long-term investors seeking exposure to a high-quality business with durable competitive advantages, I think Experian remains one worth considering.

Should you invest £5,000 in Experian Plc right now?

When investing expert Mark Rogers and his team have a stock tip, it can pay to listen. After all, the flagship Twelfth Magpie Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Experian Plc made the list?

Andrew Mackie does not hold any positions in the companies mentioned.

The post If Experian is such a great FTSE 100 stock, why are its shares down a third? appeared first on The Twelfth Magpie.

With the S&P 500 now trading at around 21 times forward earnings, analysts at Goldman Sachs forecast just a 6% return for the rest of 2026. And some academic estimates put the index’s 10-year expected return as low as 4% per annum.

In other words, the S&P 500 could prove quite underwhelming. But that means the bar for UK outperformance has never been lower.

So which FTSE shares could clear it?

The firm quietly becoming an AI powerhouse

Experian‘s (LSE:EXPN) best known as a credit bureau. And as a quick reminder, the company holds financial data on hundreds of millions of consumers globally.

But the story has quietly become something far more interesting in 2026…

Experian’s sitting on an enormous financial dataset. And it’s now monetising that data through AI-powered financial health tools, fraud prevention platforms, and analytics services for lenders.

This positions the business right at the intersection of two unstoppable structural trends: the global expansion of consumer credit and the enterprise adoption of AI.

That’s why analysts from 18 institutions covering the stock carry a consensus Buy rating, with a median 12-month price target implying over 52% upside from today’s price. And revenue is forecast to grow at a steady 8% organically, with earnings per share rising consistently through 2027.

To be fair, Experian isn’t cheap. At current multiples, any disappointment in organic growth could trigger a wave of profit-taking activity, particularly given rising AI competition from hyperscalers entering the credit analytics space.

But for investors with a multi-year horizon, the quality of the franchise looks exceptional.

An aerospace compounder nobody talks about

Melrose Industries (LSE:MRO) is another interesting pick, and one I’ve already added to my own portfolio.

After restructuring into a pure-play aerospace supplier, the group now manufactures engine components for the F-35 fighter jet and Airbus A320 family – two of the most heavily-ordered aircraft programmes in the world – among others. And with this restructuring nearing its completion, the firm’s latest results have started looking genuinely impressive.

In 2025, revenue grew 8%, adjusted operating profit lifted 23% and, critically, free cash flow turned positive for the first time in two years. And with management now targeting £600m in free cash flow by 2029, one analyst has updated their 12-month share price target to 830p – 80.8% higher than where the stock trades today!

So where’s the risk? Despite strong operational momentum, the firm’s 2026 guidance disappointed. Analysts were expecting profits to be slightly higher, and with civil airframe volumes being constrained by supply chain delays at Airbus, sentiment’s seemingly cooled in the near-term.

But if those bottlenecks are cleared, Melrose shares could quickly start marching upwards.

So what’s the verdict?

Both Experian and Melrose are world-class businesses with structural tailwinds, strong analyst backing, and valuations that look genuinely attractive relative to a stretched US market.

While neither’s free from risk, UK investors seeking quality FTSE shares that have the potential to outperform the S&P 500 may want to consider taking a closer look.

Should you invest £5,000 in Experian Plc right now?

When investing expert Mark Rogers and his team have a stock tip, it can pay to listen. After all, the flagship Twelfth Magpie Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Experian Plc made the list?

Zaven Boyrazian owns shares in Melrose Industries.

The post Prediction: 2 FTSE shares that could outperform the S&P 500 between now and 2030 appeared first on The Twelfth Magpie.

That often leads to a second belief — that serious outcomes only come from either large lump sums or consistently maxing out ISA allowances every year.

But is that really how long-term wealth is actually built?

Lump sum vs contributions

To test how wealth is actually built inside a Stocks and Shares ISA, I modelled a simple long-term scenario.

It assumes an investor starts with a £40,000 lump sum, alongside annual contributions that rise over time. The contributions start at £2,000 in the early years to £8,000 later, reflecting a typical earnings path.

The chart below shows how starting capital and ongoing contributions evolve over 20 years, assuming a 6% annual return.

At first, the result is heavily skewed towards the lump sum. In the early years, it accounts for more than 95% of total portfolio value — simply because it has more time to compound.

But that balance does not stay static.

As time passes, regular contributions build up and earlier payments begin compounding themselves. The structure of wealth gradually shifts.

By the later stages, the majority of total portfolio value is no longer coming from the initial lump sum. Instead, it’s driven by consistent investing and the compounding of those additions.

What starts as a story about starting capital becomes a story about consistent, disciplined investing over time.

Chart generated by author

Quality compounder

To reach higher long-term ISA return assumptions, investors need to find businesses capable of compounding steadily through cycles rather than relying on short-term earnings swings.

That is why Experian (LSE: EXPN) stands out to me.

FY26 was another record year, with organic revenue growth of 8% and earnings per share up 15%.

But the more important point is consistency. This is the second consecutive year the group has delivered against its medium-term framework, with margins also ahead of expectations as scale and cloud migration benefits continue to flow through.

Diversified model

The real attraction is the underlying business model.

Experian sits at the centre of global credit, fraud, and identity decisioning. Its proprietary data is deeply embedded into customer workflows, making it difficult to displace once integrated. That supports high renewal rates and continued wins across North America, Brazil, and the UK.

Strategically, the business is entering a more powerful phase. Cloud migration is largely complete, improving flexibility, while AI is being embedded into products and platforms. Management estimates more than $15bn of incremental opportunity from these capabilities, spanning credit analytics, fraud detection, and healthcare applications.

This is not just efficiency-led technology adoption. It is expanding the number of use cases where Experian’s data becomes essential to decision-making.

The main risk is valuation and expectations. With strong execution already priced in, any slowdown in growth or disruption to client demand could quickly reset sentiment.

Even so, the combination of sticky data, long-term contracts, and expanding platform use creates a compounding profile that’s difficult to replicate. But it is by no means the only long-term compounder on my radar.

Should you invest £5,000 in Experian Plc right now?

When investing expert Mark Rogers and his team have a stock tip, it can pay to listen. After all, the flagship Twelfth Magpie Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Experian Plc made the list?

Andrew Mackie owns shares in Experian.

The post The ISA strategy that could quietly turn small sums into life-changing wealth appeared first on The Twelfth Magpie.

That caution is understandable. But what often gets overlooked isn’t simply the difference in returns — it’s the point at which money starts generating more wealth than the investor contributes themselves.

When money really begins working

To explore this idea, I stripped out contributions entirely and focused on one simple question: how much of final ISA wealth actually comes from compounding?

The chart below models two savers starting with the same £30,000 lump sum — roughly in line with the average ISA balance. From that point onward, both contribute identical amounts over the following 20 years.

That means only one variable changes: investment return.

The blue line assumes a typical Cash ISA returning 4%. The green line assumes an 8% long-term return more consistent with stock market investing.

The difference is striking.

After 20 years, only around 37% of total wealth in the Cash ISA comes from compounding. At 8%, however, that figure rises to roughly 62%.

That’s the real lesson.

At lower returns, wealth remains driven largely by what the investor puts in. But at higher rates of compounding, the balance shifts. Over time, money begins generating the majority of wealth itself.

And that is arguably the point where investing starts doing the heavy lifting.

Chart generated by author

Quality compounder

One business that increasingly fits this idea of compounding is Experian (LSE:EXPN).

Unlike more cyclical businesses, Experian has built its growth around data, recurring relationships and platforms that become increasingly embedded inside customer operations.

That was evident again in FY26.

Organic revenue rose 8%, while earnings per share climbed 15%. Margins also expanded as cloud migration costs began falling and the growing scale of its platforms improved efficiency.

But what stands out to me is not simply growth — it’s the quality and consistency behind it.

Experian renewed 100% of its large North American strategic accounts, often on longer and higher-value contracts. Across credit, fraud, and identity, its platforms are becoming more deeply integrated into customer workflows, creating higher switching costs and increasingly predictable revenue.

Artificial intelligence is also changing the debate.

Rather than threatening the business model, management believes AI is increasing demand for trusted, regulated, and explainable data. That matters because over 90% of revenue still relies on proprietary data sets and decisioning tools that are difficult to replicate.

What could go wrong?

Competition remains intense and the shares aren’t cheap with a price-to-earnings multiple of 21, meaning expectations are already high. Regulation also remains an important consideration. As a business built around consumer and commercial data, the company operates in tightly governed markets where changes to privacy rules or data usage could affect growth.

Yet, for me, the attraction lies elsewhere.

The earlier chart showed how wealth creation accelerates when compounding is allowed to work uninterrupted. Businesses like Experian operate in much the same way — and it’s exactly why I continue looking for other companies with similar long-term characteristics.

Should you invest £5,000 in Experian Plc right now?

When investing expert Mark Rogers and his team have a stock tip, it can pay to listen. After all, the flagship Twelfth Magpie Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Experian Plc made the list?

Andrew Mackie does not hold any positions in the companies mentioned.

The post How much of a Stocks and Shares ISA is actually built by compounding? appeared first on The Twelfth Magpie.

Notable supporters

I’m referring to Experian (LSE:EXPN). The global data and analytics powerhouse has seen its share price fall by 32% over the past year.

At the moment, the average target price for the coming year from the 24 contributing analysts is 3,904p. So from the current share price of 2,734p, that’s a potential gain of 43%. Notable inclusions include Barclays, with the research team forecasting 4,500p, and Goldman Sachs at 4,060p.

Of course, these are just subjective views. Even though the analysts are experts in their field, there’s no guarantee that the stock will hit these levels over the next year. But the main takeaway for me is that the broad consensus is that the stock has momentum to head higher, even if the exact price to target is up for discussion.

One eye on the past

Even with the strong outlook, some investors might be concerned with the size of the share price fall in the last year. One reason for this is concern around the broader lending environment. Higher interest rates have slowed mortgage activity and reduced borrowing volumes across parts of the US economy. Experian generates around two-thirds of overall revenue from the US, so that’s a key area. Since Experian earns money from credit checks and lending activity, any slowdown in consumer borrowing can weigh on sentiment.

Another point has been the ongoing battle around credit scoring. The industry is facing disruption from regulatory scrutiny and increased competition from other credit scoring providers. This is a risk going forward, as pricing pressure could hurt profitability in parts of the mortgage ecosystem.

Balancing everything out

Despite the risks, the underlying business continues to perform well. In the latest full-year results, Experian delivered 8% revenue growth, while profits also increased.

More importantly, I like the fact that Experian is becoming less dependent on traditional credit reporting. It has been working on ancillary tools, such as fraud prevention and AI-driven analytics. These are fast-growing markets, which could easily add more significant revenue streams further down the line.

With a price-to-earnings ratio of 23.91, it’s well above the FTSE 100 index average, and therefore not a cheap stock. But if it can shrug off some of the competition and enjoy stronger consumer activity in the US, I believe it could make back a lot of the share price losses from the last year.

So even though I think a 43% rally in the coming year could be a little optimistic, I do feel it’s a stock worth considering for investors.

Jon Smith has no positions in the shares mentioned.

The post Analysts think this FTSE 100 stock could rally 43% in the coming year appeared first on The Twelfth Magpie.

Two caught my eye — each could be worth a closer look for investors hunting potentially undervalued Footsie shares.

What AI disruption?

Credit checking giant Experian (LSE:EXPN) has suffered a shocking fall from grace, slumping 33% since last summer.

On 18 May, however, UBS maintained a Buy recommendation on the stock, reiterating its 3,700p price target. If that was to come to fruition, which isn’t guaranteed of course, then investors could be looking at a 39% uplift from today’s price.

Experian has sold off in part due to market fears that AI might disrupt parts of the traditional credit-bureau business model. This is a key risk moving forward. 

Yet UBS points out that Experian’s core datasets are proprietary and highly integrated into workflows. Instead of being replaced, Experian is successfully implementing its own AI-driven products while continuing to expand into areas like advanced verification and fraud prevention. 

Here are some forward-thinking deals announced by Experian recently: 

• It has built the UK’s first credit score tool natively inside ChatGPT.
• Embedding analytics data directly into ServiceNow workflows so corporate AI agents can instantly approve loans or flag fraud.
• It has formed a security layer for agentic AI shopping with cybersecurity firm Akamai (helping block malicious bots). 

Back in February, UBS said it was comfortable modelling 10% earnings growth over the medium term. Yet after the sharp pullback, Experian’s trading at just 18 times forward earnings. 

If the firm can continue compounding and quell fears about AI disruption, then the stock is almost certainly undervalued today. The City certainly thinks so, with the average price target among analysts sitting almost 50% higher at 4,048p. 

Note, Experian reports its full-year results tomorrow (20 May), when it’s expected to post 8% organic revenue growth. But all eyes will be on the outlook for FY27 given the ongoing macroeconomic uncertainty. 

Luxury recovery play

The second Footsie stock is luxury fashion group Burberry (LSE:BRBY). The shares have slumped 49% in five years.

However, that hasn’t stopped Deutsche giving the stock a 1,480p price target (35% higher). That would be a welcome outcome for shareholders, who’ve watched Burberry’s sales struggle amid global inflation and weakness in China.

Burberry also went after more affluent customers, but its existing shoppers baulked at the new ultra-luxury prices. Under CEO Joshua Schulman, though, the 170-year-old brand is plotting a turnaround centred upon cost-cutting and refocusing on its iconic trench coats and scarves.

Looking at the FY26 results, there are some very encouraging signs. For a start, Burberry returned to comparable sales growth from Q2, culminating in double-digit growth in Greater China and Americas in Q4.

Meanwhile, adjusted operating profit jumped from £26m to £160m. E-Commerce sales were up strongly, particularly among younger shoppers, and bag sales (including the newer Cotswolds bag) are doing well again.

The biggest current risk is rising inflation, which might cause aspirational shoppers to tighten belts again. Management is cautious for FY27.

But with early signs that Burberry is reinvigorating the brand, a forward earnings multiple of 25 could end up looking cheap a few years from now. As such, I reckon the stock’s worth a closer look.

Ben McPoland has no positions in any of the companies mentioned.

The post 2 FTSE 100 stocks that are undervalued, according to City brokers appeared first on The Twelfth Magpie.

Experian (LSE:EXPN) shares are down 36% from their highs. So is now the time to strike?

How cheap is the stock?

In valuation terms, Experian shares look like a once-in-a-decade opportunity. The stock is trading at a price-to-book (P/B) ratio of 5.9.

Source: Fiscal.ai

The last few months aside, it hasn’t traded at that level in the last 10 years. On average, it’s been more like 8.98.

If it gets back to this level, investors are looking at a 52% gain. And that’s not factoring anything in terms of growth.

The big question is whether it’s likely to get back there. The company has been facing two big challenges recently.

Disintermediation

The first threat is disintermediation. This comes from Fair Isaac Corporation also known as FICO. 

US lenders use FICO scores to assess borrowers. FICO licenses its algorithm to Experian (and others) who apply this to their data to create a score.

That’s a very profitable business for Experian. FICO, however, is looking to license directly to lenders, bypassing the FTSE 100 firm in the process.

The US is a huge market for Experian, so the threat is one to take seriously. But the company has been hitting back.

Experian’s response

In response, Experian – along with Equifax and TransUnion – have come up with their own algorithm. It’s called Vantage.

If they can convince lenders to use this instead of FICO, the disintermediation threat collapses. That, however, won’t be entirely straightforward.

Vantage has been approved by the US regulators. But there’s still a question of whether lenders will actually use it. 

A lot comes down to what happens when lenders try to sell mortgages on. Whether they’ll achieve full value using Vantage instead of FICO remains to be seen.

Artificial intelligence

The other issue is artificial intelligence (AI). The concern here is that lenders might try to use AI products instead of Experian’s reports.

That won’t work for banks originating mortgages that they want to sell on. But that’s only one part of the business. 

Credit data is also used for things like credit cards and buy-now-pay-later loans. And those don’t face the same regulatory challenges.

The big question is whether demand for Experian’s reports will be as strong in these areas. I think that remains to be seen.

Data assets

Experian’s key asset is its data. This is virtually impossible for a new AI startup to replicate, so it’s hard to see competition on that front. 

The question, however, is how significant that will be. Lenders might think they can use AI to do more with less data. Whether or not they can remains to be seen. But the stock market seems to think there’s a real threat here. 

If that’s right, Experian could well find itself in a much weaker position when it comes to pricing. And that’s the problem for the business.

What should investors do?

There’s a chance that a decade-low multiple could be a huge buying opportunity. But investors need to be honest with themselves about the threats.

Exactly how all of this resolves I’m not sure. I do think, however, that there are much more obvious opportunities elsewhere at the moment.

Stephen Wright has no position in any of the companies mentioned.

The post 36% off its highs, is Experian one of the best FTSE 100 stocks to buy right now? appeared first on The Twelfth Magpie.

Investing in shares that pay dividends is a simple and popular way to aim for that extra cash without taking on a second job.

For Britons, one of the smartest ways to invest is with a Stocks and Shares ISA, because any gains earned here are free from income tax. Over time, that tax shield can make a noticeable difference, especially as income grows.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

So what does it take to generate £100 a week?

Maths time

A hundred quid a week is £5,200 a year. If an investor targets a dividend yield of 6%-7%, the maths is fairly straightforward:

• At 6%, it would require roughly £86,700 invested.
• At 7%, it’s closer to £74,300. 

Split the difference, and a realistic target sits at £75,000-£85,000. That may sound like a lot but it can be built over time.

The FTSE 100 has delivered annnualised total returns of about 9.5% over the past decade (with dividends reinvested). If that average holds, it would take about 10 years with an investment of £400 a month.

It might sound counterintuitive to spend money to make money, but once in place, it can pay itself off quickly. Plus, you end up with a solid pot of savings for retirement.

Which stocks?

Of course, stock selection matters. The London Stock Exchange is full of quality dividend stocks, but the biggest winners are often global businesses rather than UK-focused names.

Long-term outperformance tends to come from scalable models like data and software, or from well-timed exposure to cyclical sectors such as commodities and defence.

A good example is global information services company Experian (LSE: EXPN). This year’s been tough but between 2015 and 2025, it delivered a total return of over 310% — roughly 15% a year on average. That’s far ahead of the wider market.

Looking at its latest results, growth remains steady despite fears around AI risks. Revenue’s been rising in the high single digits, supported by strong demand for credit data and analytics, particularly in North America.

What’s the catch?

While Experian’s margins and cash generation are solid, it only pays a modest dividend with a yield of around 1%-2%. So after the 10-year growth period, an investor would need to pivot more into higher-yielding shares.

Valuation’s also a concern. The shares trade at a premium price-to-earnings ratio compared to the FTSE average. That reflects its quality, but it does leave less room for error.

If consumer lending activity slows or regulatory changes hit profits, the share price could take a hit.

So is it worth considering?

For long-term investors, Experian shows how combining steady growth with rising dividends can accelerate income over time.

With generally positive analyst sentiment, I think it’s worth considering. Many brokers rate the stock as a Buy or Hold, with forecasts pointing to continued earnings growth. 

It’s not the highest yielder but it demonstrates an important point: building a £100 weekly income isn’t just about chasing yield. Getting there requires a mix of income shares and high quality, growth-focused companies.

The post How much should someone invest to target a £100 weekly second income? appeared first on The Twelfth Magpie.

Analysts, however, expect the stock to bounce back strongly. So with the average price target 54% above the current level of the stock, is this a rare chance to buy? 

A FTSE 100 heavyweight

Experian is one of the FTSE 100’s most impressive businesses. It has a big competitive advantage that doesn’t take huge capital investments to maintain. 

The firm’s edge comes from the data it uses to produce its reports. This comes from a vast number of sources and includes a lot of information that isn’t publicly available.

On top of this, Experian’s credit scores have been a key asset for US lenders wanting to resell mortgages they originate. While this has evolved recently, it’s still largely the case.

That’s why the company’s shares have always traded at above-average multiples. But the stock market currently thinks the business might become an artificial intelligence (AI) casualty.

The AI disruption threat

AI won’t be able to match Experian’s product – it doesn’t have the data. But the concern is that it might be able to offer a close-enough alternative at a fraction of the price.

The FTSE 100 firm has an extremely strong position in the mortgage market, but that’s only one part of the business. The rest is things like payday loans and credit cards. 

In these cases, lenders might think an AI-driven background check that uses less data is good enough at a much lower price. And that’s the real threat for Experian to deal with.

This is why the stock has been falling. But the question for investors is whether it justifies a 34% fall from its highs, or whether investors are overreacting to a new and unusual threat.

How resilient is the business?

There hasn’t yet been any sign of disruption in Experian’s results. The latest update reported 8% organic revenue growth and it expects this to continue in the next few months.

Investors, though, need to think carefully about this. With the kind of threat the company is facing, things can change suddenly and without warning. 

That means the insights investors can get by looking at past results are very limited. This is always the case to some extent, but it’s especially true with Experian right now.

If AI competition starts to make progress in key markets, the situation could change very quickly. So investors need to look past the numbers to assess the firm’s resiliency.

Time to buy?

At its highs, a £10,000 investment in Experian bought 244 shares. With the stock now well below that level, investors can get 373 shares for the same amount of cash.

Analyst price targets suggest the stock is expected to bounce back strongly in the near future. But I think investors need to be a bit careful with this one.

While its core mortgage business is very well-protected, I can see some big potential threats elsewhere. And those need to be taken seriously.

I think the rise of AI is creating some unusually good investment opportunities. But Experian isn’t the stock I’m scrambling to buy right now to take advantage.

The post £10,000 buys 373 shares in this FTSE 100 heavyweight that’s tipped to surge in 2026 appeared first on The Twelfth Magpie.